We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
10 Year Est. Return
AUM
$445M
AUM Growth
+$12.5M
Cap. Flow
+$42M
Cap. Flow %
9.43%
Top 10 Hldgs %
17.71%
Holding
180
New
7
Increased
57
Reduced
108
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 43.46%
2 Technology 20.4%
3 Consumer Discretionary 13.04%
4 Industrials 6.73%
5 Financials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GKOS icon
126
Glaukos
GKOS
$9.83B
$1.28M 0.29%
30,166
-1,013
-3% -$50K
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$121B
$1.28M 0.29%
4,415
+451
+11% +$137K
VRNS icon
128
Varonis Systems
VRNS
$4.59B
$1.28M 0.29%
53,619
-1,799
-3% -$41.1K
AXNX
129
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.26M 0.28%
20,025
-10,013
-33% -$664K
UNVR
130
DELISTED
Univar Solutions Inc.
UNVR
$1.25M 0.28%
39,627
+6,924
+21% +$199K
AZEK
131
DELISTED
The AZEK Co
AZEK
$1.23M 0.28%
59,002
+23,018
+64% +$426K
AMD icon
132
Advanced Micro Devices
AMD
$776B
$1.22M 0.27%
18,832
+2,283
+14% +$151K
TTEK icon
133
Tetra Tech
TTEK
$8.49B
$1.21M 0.27%
41,395
-18,270
-31% -$528K
YETI icon
134
Yeti Holdings
YETI
$3.71B
$1.19M 0.27%
28,683
+5,206
+22% +$195K
RPD icon
135
Rapid7
RPD
$645M
$1.19M 0.27%
34,742
+7,316
+27% +$262K
LULU icon
136
lululemon athletica
LULU
$13.5B
$1.17M 0.26%
3,706
-72
-2% -$23.7K
ALB icon
137
Albemarle
ALB
$13.9B
$1.17M 0.26%
5,384
-105
-2% -$28K
SUM
138
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.17M 0.26%
40,345
-1,355
-3% -$37.3K
NXPI icon
139
NXP Semiconductors
NXPI
$57.8B
$1.16M 0.26%
7,330
+907
+14% +$144K
GTLS
140
DELISTED
Chart Industries
GTLS
$1.15M 0.26%
10,199
-1,414
-12% -$227K
BCC icon
141
Boise Cascade
BCC
$2.69B
$1.15M 0.26%
16,375
-551
-3% -$37.6K
KRTX
142
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.14M 0.26%
5,871
-197
-3% -$42.2K
HLI icon
143
Houlihan Lokey
HLI
$8.77B
$1.13M 0.25%
+12,713
New +$1.14M
CWST icon
144
Casella Waste Systems
CWST
$5.71B
$1.11M 0.25%
13,749
-562
-4% -$45.1K
CALY
145
Callaway Golf Company
CALY
$3.32B
$1.07M 0.24%
54,776
-1,838
-3% -$36.2K
KNSL icon
146
Kinsale Capital Group
KNSL
$8.12B
$1.04M 0.23%
3,923
+1,643
+72% +$474K
BMRN icon
147
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.04M 0.23%
10,124
-197
-2% -$18.5K
SAIA icon
148
Saia
SAIA
$9.27B
$1.03M 0.23%
4,793
-161
-3% -$35.1K
EW icon
149
Edwards Lifesciences
EW
$49.6B
$1.02M 0.23%
13,568
-51,553
-79% -$3.97M
SF
150
Stifel
SF
$12.6B
$995K 0.22%
25,325
-850
-3% -$33.6K

Similar funds

EFG Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EFG Asset Management held 180 positions worth $445M, up 2.9% from $433M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EFG Asset Management deployed $42M of net new capital in Q4 2022, opening 7 new positions and adding to 57 existing holdings. Its largest new stake was ProShares Ultra Semiconductors: 12,182,008 shares worth $3.05M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $5.6M trimmed.

  • EFG Asset Management's largest Q4 2022 buy was ProShares Ultra Semiconductors: 12,182,008 shares worth $3.05M.
  • EFG Asset Management added most to CoStar Group in Q4 2022, an estimated $1.08M increase.
  • EFG Asset Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.6M.
  • EFG Asset Management fully exited NEVRO CORP. in Q4 2022, selling an estimated $1.57M.
  • EFG Asset Management's ten largest holdings make up 18% of its $445M portfolio in Q4 2022.
  • EFG Asset Management opened 7 new positions and closed 8 in Q4 2022.
  • EFG Asset Management's portfolio value rose 2.9% quarter-over-quarter to $445M.

Based on EFG Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.